Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v1-EN
Language French English
Date Updated 2023-02-06 2023-01-17
Drug Identification Number 02146908 02146908
Brand name BIAXIN BIAXIN
Common or Proper name CLARITHROMYCIN CLARITHROMYCIN
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients CLARITHROMYCIN CLARITHROMYCIN
Strength(s) 125MG 125MG
Dosage form(s) GRANULES FOR SUSPENSION GRANULES FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 55ML, 105ML 55ML
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-04-05 2023-03-15
Actual start date
Estimated end date 2023-06-13 2023-04-11
Actual end date 2023-02-02
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments